Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Abstract
The development of arteriosclerosis after heart transplantation plays a major role in decreased graft and patient survival. Although several pathogenic mechanisms have been proposed for the development of posttransplant coronary artery disease (CAD), a significant amount of accumulating evidence suggests that cytomegalovirus is a critical factor in this disease. Because post-transplant CAD is often a silent disease and early detection escapes conventional angiography, physicians must maintain close surveillance of heart transplant patients and institute prophylaxis in high-risk groups. In addition to targeting conventional risk factors, prophylaxis against CMV disease should decrease the incidence of the disease.
View details for PubMedID 11565583